Australia Australia | Apotex Worldwide 

Message from Managing Director, Asia Pacific

In July 2004, Apotex Inc. acquired the GenRx business in Australia. In September 2007, GenRx changed its name to Apotex Pty Ltd (Apotex). Today, the Apotex product portfolio represents one of the most comprehensive ranges within the Australian market, comprising over 300 products across a broad range of therapeutic areas, supported by a strong pipeline and focus on first-to-market launches, innovative and best-in-class professional services and training, and significant business partnerships across products and services.

Apotex is committed to improving outcomes for patients through access to affordable, innovative, and high-quality healthcare solutions. We believe in a strong healthcare system, and a thriving generic medicines industry.

At Apotex, our ability to adapt, diversify and evolve our offer enables us find new ways to partner with pharmacies to unlock value, both in and out of the dispensary. This is how Apotex is working to sustain Australia’s world-class PBS and ensure the viability of our business into the future.

We look forward to supporting the business and profession of pharmacy, as pharmacists position themselves to take advantage of the opportunities that this changing market presents.

Roger Millichamp
Managing Director, Asia Pacific

Roger Millichamp
Roger Millichamp
Managing Director, Asia Pacific